SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 89 filers reported holding SERES THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $263,000 | +55.6% | 38,271 | +2.5% | 0.00% | – |
| Q4 2018 | $169,000 | -70.9% | 37,325 | -51.1% | 0.00% | – |
| Q3 2018 | $580,000 | +31.8% | 76,344 | +49.4% | 0.00% | – |
| Q2 2018 | $440,000 | +13.7% | 51,111 | -2.9% | 0.00% | – |
| Q1 2018 | $387,000 | -25.1% | 52,659 | +3.3% | 0.00% | – |
| Q4 2017 | $517,000 | -39.7% | 50,957 | -4.6% | 0.00% | -100.0% |
| Q3 2017 | $857,000 | +41.9% | 53,420 | 0.0% | 0.00% | – |
| Q2 2017 | $604,000 | -51.3% | 53,420 | -51.5% | 0.00% | -100.0% |
| Q1 2017 | $1,241,000 | +30.2% | 110,076 | +14.4% | 0.00% | 0.0% |
| Q4 2016 | $953,000 | +1.8% | 96,251 | +26.4% | 0.00% | 0.0% |
| Q3 2016 | $936,000 | -39.3% | 76,173 | +43.5% | 0.00% | 0.0% |
| Q2 2016 | $1,542,000 | +130.1% | 53,093 | +110.4% | 0.00% | 0.0% |
| Q1 2016 | $670,000 | -25.0% | 25,239 | -0.9% | 0.00% | 0.0% |
| Q4 2015 | $893,000 | +18.3% | 25,459 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $755,000 | – | 25,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |